Comparing Mounjaro (Tirzepatide) and Semaglutide When comparing Mounjaro and Semaglutide's efficacy in weight loss, both medications have shown impressive results
CrossRef Non-alcoholic fatty liver disease in type 2 diabetes: Emerging evidence of benefit of peroxisome proliferator-activated receptors agonists and incretin-based therapies Subhodip Pramanik, Partha Pal, Sayantan Ray World Journal of Methodology.2024;[Epub] CrossRef Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence Salvatore Corrao, Chiara Pollicino, Dalila Maggio, Alessandra Torres, Christiano Argano Frontiers in Endocrinology.2024;[Epub] CrossRef Assessing the therapeutic potential of long-chain isomaltooligosaccharides in diabetic and hyperlipidemic rats Onrapak Reamtong, Rattiya Waeonukul, Pattaneeya Prangthip Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef Deciphering the GutLiver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease Samradhi Singh, Mona Kriti, Roberto Catanzaro, Francesco Marotta, Mustafa Malvi, Ajay Jain, Vinod Verma, Ravinder Nagpal, Rajnarayan Tiwari, Manoj Kumar Livers.2024
Table of Contents What Cagrilintide and Retatrutide Are and How They Work Approved Uses and Current Clinical Evidence in the UK How These Medicines May Affect Men Specifically Dosage, Administration, and What to Expect Side Effects, Risks, and Safety Considerations Availability on the NHS and Next Steps for Treatment Scientific References Frequently Asked Questions What Cagrilintide and Retatrutide Are and How They Work Cagrilintide is a long-acting amylin analogue that promotes satiety and slows gastric emptying, while retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite, enhance insulin secretion, and increase energy expenditure
Syst Rev (2019) 8:279
Requirements: Five-minute health questionnaire and provider review
Services Include: Hormone Replacement Therapy for Men & Women, Medical Weight Loss, Regenerative & Peptide Therapies
